Form 4: BioStar Ventures III, L.P. Acquires Warrants in Autonomix Medical, Inc.

BioStar Ventures III, L.P., a 10% owner of Autonomix Medical, Inc., acquired warrants to purchase 1,088,000 shares of common stock on June 18, 2024.

Summary

• On June 18, 2024, BioStar Ventures III, L.P. acquired warrants to purchase 1,088,000 shares of Autonomix Medical, Inc. common stock.
• The exercise price of the warrants is $0.001 per share.
• The warrants expire on January 29, 2029.
• The ability to exercise the warrants is subject to a beneficial ownership limitation, initially set at 4.99% of the outstanding common stock, and can be adjusted up to 9.99% with a 61-day notice period to the issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of warrant acquisition. The potential positive is the confidence shown by a large shareholder, but it's not overtly bullish.

Positives

• The acquisition of warrants by a significant shareholder like BioStar Ventures III, L.P. could signal confidence in Autonomix Medical, Inc.'s future prospects.

Risks

• The beneficial ownership limitation on exercising the warrants could restrict BioStar Ventures III, L.P.'s ability to fully capitalize on the warrants if it would exceed the ownership threshold.
• The adjustment of the beneficial ownership limitation requires a 61-day notice, potentially delaying the exercise of warrants if BioStar Ventures III, L.P. seeks to increase its ownership stake.

Future Outlook

The document does not contain specific forward-looking statements regarding Autonomix Medical, Inc.'s future performance, but the warrant acquisition suggests a potential for increased ownership by BioStar Ventures III, L.P. in the future.

Industry Context

Form 4 filings are routine disclosures of transactions by company insiders and large shareholders. This filing indicates activity by a significant shareholder in Autonomix Medical, Inc., which could be of interest to other investors in the medical device sector.

Stakeholder Impact

• The warrant acquisition could potentially impact shareholders by increasing the number of shares outstanding if the warrants are exercised, which could dilute existing shareholders' ownership.

Key Dates

Keywords

Autonomix Medical, BioStar Ventures, Warrants, Beneficial Ownership, Form 4, AMIX